antibody drug conjugate treatment in lung cancer - onctalk lung 2023
Published 3 months ago • 37 plays • Length 3:05Download video MP4
Download video MP3
Similar videos
-
2:32
toxicities in antibody drug conjugate treatment - onctalk lung 2023
-
3:54
what are antibody drug conjugates? - onctalk lung 2023
-
7:29
antibody drug conjugates: what are antibodies? - onctalk lung 2023
-
3:49
q&a: what are next steps in antibody drug conjugates? - onctalk lung 2023
-
3:44
bispecific antibodies in lung cancer - onctalk lung 2023
-
2:14
q&a: what are costs and side effects of antibody drug conjugates? - onctalk lung 2023
-
1:58
the role of antibody drug conjugates in lung cancer care
-
3:58
local therapy for limited metastatic nsclc - targeted therapies in lung cancer 2023
-
3:16
q&a: what are toxicities in bispecific antibody treatments? - onctalk lung 2023
-
2:30
advances in oligometastatic disease - onctalk lung 2023
-
2:22
aegean trial: perioperative durvalumab for nsclc - onctalk lung 2023
-
5:30:11
full event mainstage 2023 targeted therapies in lung cancer patient forum on-demand
-
5:31
biomarkers in nsclc - targeted therapies in lung cancer 2023
-
17:40
liquid biopsies: current applications - grace targeted therapies in lung cancer patient forum 2021
-
4:35
the importance of biomarker testing: what is liquid biopsy? - targeted therapies in lung cancer 2023
-
1:50
is alectinib an option for patients with dctn1 alk disease?- targeted therapies in lung cancer 2023
-
3:49
ret fusion treatment: selpercatinib - targeted therapies in lung cancer 2023
-
3:21
bispecific antibodies: amivantamab - onctalk lung 2023